The karyopherin CRM1 is required for dendritic cell maturation

Immunobiology

Volumn 215, Issue 5, 2010, Pages 370-379

  Chemnitz, J ^a   Turza, Nadine ^b   Hauber, Ilona ^a   Steinkasserer, Alexander ^b   Hauber, Joachim ^a  

^a LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Antigen presenting cells; CD83; CRM1; Dendritic cells; MRNA

Indexed keywords

B7 ANTIGEN; CD14 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; EXPORTIN 1; LEPTOMYCIN B; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA;

ARTICLE; CELL FUNCTION; CELL MATURATION; CELL SURFACE; CELLULAR IMMUNITY; CONTROLLED STUDY; CORRELATIONAL STUDY; CYTOPLASM; DENDRITIC CELL; DOWN REGULATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; MIXED LYMPHOCYTE REACTION; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; RNA ANALYSIS; RNA TRANSPORT; T LYMPHOCYTE; WESTERN BLOTTING;

ANTIGENS, CD; CELL DIFFERENTIATION; DENDRITIC CELLS; FATTY ACIDS, UNSATURATED; HUMANS; IMMUNOGLOBULINS; KARYOPHERINS; MEMBRANE GLYCOPROTEINS; NEUTROPHILS; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 77950936880     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2009.05.008     Document Type: Article

References (46)

1. Aerts-Toegaert C., Heirman C., Tuyaerts S., Corthals J., Aerts J.L., Bonehill A., Thielemans K., Breckpot K. CD83 expression on dendritic cells and T cells: correlation with effective immune responses. Eur. J. Immunol. 2007, 37:686-695.
2. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., Pulendran B., Palucka K. Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000, 18:767-811.
3. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
4. Bevec D., Jaksche H., Oft M., Wöhl T., Himmelspach M., Pacher A., Schebesta M., Koettnitz K., Dobrovnik M., Csonga R., Lottspeich F., Hauber J. Inhibition of HIV-1 replication in lymphocytes by mutants of the Rev cofactor eIF-5A. Science 1996, 271:1858-1860.
5. Breloer M., Fleischer B. CD83 regulates lymphocyte maturation, activation and homeostasis. Trends Immunol. 2008, 29:186-194.
6. Brennan C.M., Gallouzi I.E., Steitz J.A. Protein ligands to HuR modulate its interaction with target mRNAs in vivo. J. Cell Biol. 2000, 151:1-14.
7. Chemnitz J., Pieper D., Grüttner C., Hauber J. Phosphorylation of the HuR ligand APRIL by casein kinase 2 regulates CD83 expression. Eur. J. Immunol. 2009, 39:267-279.
8. Cramer S.O., Trumpfheller C., Mehlhoop U., More S., Fleischer B., von Bonin A. Activation-induced expression of murine CD83 on T cells and identification of a specific CD83 ligand on murine B cells. Int. Immunol. 2000, 12:1347-1351.
9. Dieu M.C., Vanbervliet B., Vicari A., Bridon J.M., Oldham E., Ait-Yahia S., Briere F., Zlotnik A., Lebecque S., Caux C. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med. 1998, 188:373-386.
10. Erkmann J.A., Kutay U. Nuclear export of mRNA: from the site of transcription to the cytoplasm. Exp. Cell Res. 2004, 296:12-20.
11. Fornerod M., Ohno M., Yoshida M., Mattaj I.W. CRM1 is an export receptor for leucine-rich nuclear export signals. Cell 1997, 90:1051-1060.
12. Fries B., Heukeshoven J., Hauber I., Grüttner C., Stocking C., Kehlenbach R.H., Hauber J., Chemnitz J. Analysis of nucleocytoplasmic trafficking of the HuR ligand APRIL and its influence on CD83 expression. J. Biol. Chem. 2007, 282:4504-4515.
13. Fujimoto Y., Tu L., Miller A.S., Bock C., Fujimoto M., Doyle C., Steeber D.A., Tedder T.F. CD83 expression influences CD4+ T cell development in the thymus. Cell 2002, 108:755-767.
14. Fukuda M., Asano S., Nakamura T., Adachi M., Yoshida M., Yanagida M., Nishida E. CRM1 is responsible for intracellular transport mediated by the nuclear export signal. Nature 1997, 390:308-311.
15. Hauber I., Bevec D., Heukeshoven J., Krätzer F., Horn F., Choidas A., Harrer T., Hauber J. Identification of cellular deoxyhypusine synthase as a novel target for antiretroviral therapy. J. Clin. Invest. 2005, 115:76-85.
16. Hock B.D., Kato M., McKenzie J.L., Hart D.N. A soluble form of CD83 is released from activated dendritic cells and B lymphocytes, and is detectable in normal human sera. Int. Immunol. 2001, 13:959-967.
17. Hutten S., Kehlenbach R.H. CRM1-mediated nuclear export: to the pore and beyond. Trends Cell Biol. 2007, 17:193-201.
18. Iking-Konert C., Cseko C., Wagner C., Stegmaier S., Andrassy K., Hansch G.M. Transdifferentiation of polymorphonuclear neutrophils: acquisition of CD83 and other functional characteristics of dendritic cells. J. Mol. Med. 2001, 79:464-474.
19. Izaurralde E. Directing mRNA export. Nat. Struct. Mol. Biol. 2004, 11:210-212.
20. Jang B.C., Munoz-Najar U., Paik J.H., Claffey K., Yoshida M., Hla T. Leptomycin B, an inhibitor of the nuclear export receptor CRM1, inhibits COX-2 expression. J. Biol. Chem. 2003, 278:2773-2776.
21. Keene J.D. Why is Hu where? Shuttling of early-response-gene messenger RNA subsets. Proc. Natl. Acad. Sci. USA 1999, 96:5-7.
22. Kimura T., Hashimoto I., Nagase T., Fujisawa J. CRM1-dependent, but not ARE-mediated, nuclear export of IFN-alpha1 mRNA. J. Cell Sci. 2004, 117:2259-2270.
23. Klein E., Koch S., Borm B., Neumann J., Herzog V., Koch N., Bieber T. CD83 localization in a recycling compartment of immature human monocyte-derived dendritic cells. Int. Immunol. 2005, 17:477-487.
24. Kozlow E.J., Wilson G.L., Fox C.H., Kehrl J.H. Subtractive cDNA cloning of a novel member of the Ig gene superfamily expressed at high levels in activated B lymphocytes. Blood 1993, 81:454-461.
25. Kruse M., Rosorius O., Krätzer F., Bevec D., Kuhnt C., Steinkasserer A., Schuler G., Hauber J. Inhibition of CD83 cell surface expression during dendritic cell maturation by interference with nuclear export of CD83 mRNA. J. Exp. Med. 2000, 191:1581-1590.
26. Kudo N., Khochbin S., Nishi K., Kitano K., Yanagida M., Yoshida M., Horinouchi S. Molecular cloning and cell cycle-dependent expression of mammalian CRM1, a protein involved in nuclear export of proteins. J. Biol. Chem. 1997, 272:29742-29751.
27. Kudo N., Matsumori N., Taoka H., Fujiwara D., Schreiner E.P., Wolff B., Yoshida M., Horinouchi S. Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region. Proc. Natl. Acad. Sci. USA 1999, 96:9112-9117.
28. Kudo N., Wolff B., Sekimoto T., Schreiner E.P., Yoneda Y., Yanagida M., Horinouchi S., Yoshida M. Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1. Exp. Cell Res. 1998, 242:540-547.
29. Lechmann M., Berchtold S., Hauber J., Steinkasserer A. CD83 on dendritic cells: more than just a marker for maturation. Trends Immunol. 2002, 23:273-275.
30. Lechmann M., Krooshoop D.J., Dudziak D., Kremmer E., Kuhnt C., Figdor C.G., Schuler G., Steinkasserer A. The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells. J. Exp. Med. 2001, 194:1813-1821.
31. Lechmann M., Zinser E., Golka A., Steinkasserer A. Role of CD83 in the immunomodulation of dendritic cells. Int. Arch. Allergy Immunol. 2002, 129:113-118.
32. Matilla A., Radrizzani M. The Anp32 family of proteins containing leucine-rich repeats. Cerebellum 2005, 4:7-18.
33. McKinsey T.A., Chu Z., Tedder T.F., Ballard D.W. Transcription factor NF-kappaB regulates inducible CD83 gene expression in activated T lymphocytes. Mol. Immunol. 2000, 37:783-788.
34. Mellman I., Steinman R.M. Dendritic cells: specialized and regulated antigen processing machines. Cell 2001, 106:255-258.
35. Moore M.J., Rosbash M. Cell biology. TAPping into mRNA export. Science 2001, 294:1841-1842.
36. Ossareh-Nazari B., Bachelerie F., Dargemont C. Evidence for a role of CRM1 in signal-mediated nuclear protein export. Science 1997, 278:141-144.
37. Pollard V.W., Malim M.H. The HIV-1 Rev protein. Annu. Rev. Microbiol. 1998, 52:491-532.
38. Prechtel A.T., Chemnitz J., Schirmer S., Ehlers C., Langbein-Detsch I., Stülke J., Dabauvalle M.C., Kehlenbach R.H., Hauber J. Expression of CD83 is regulated by HuR via a novel cis-active coding region RNA element. J. Biol. Chem. 2006, 281:10912-10925.
39. Prechtel A.T., Steinkasserer A. CD83: an update on functions and prospects of the maturation marker of dendritic cells. Arch. Dermatol. Res. 2007, 299:59-69.
40. Prechtel A.T., Turza N.M., Theodoridis A.A., Steinkasserer A. CD83 knockdown in monocyte-derived dendritic cells by small interfering RNA leads to a diminished T cell stimulation. J. Immunol. 2007, 178:5454-5464.
41. Scholler N., Hayden-Ledbetter M., Dahlin A., Hellstrom I., Hellstrom K.E., Ledbetter J.A. Cutting edge: CD83 regulates the development of cellular immunity. J. Immunol. 2002, 168:2599-2602.
42. Schütz S., Chemnitz J., Spillner C., Frohme M., Hauber J., Kehlenbach R.H. Stimulated expression of mRNAs in activated T cells depends on a functional CRM1 nuclear export pathway. J. Mol. Biol. 2006, 358:997-1009.
43. Zhou L.J., Schwarting R., Smith H.M., Tedder T.F. A novel cell-surface molecule expressed by human interdigitating reticulum cells, Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily. J. Immunol. 1992, 149:735-742.
44. Zhou L.J., Tedder T.F. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc. Natl. Acad. Sci. USA 1996, 93:2588-2592.
45. Zinser E., Lechmann M., Golka A., Lutz M.B., Steinkasserer A. Prevention and treatment of experimental autoimmune encephalomyelitis by soluble CD83. J. Exp. Med. 2004, 200:345-351.
46. Zinser E., Turza N., Steinkasserer A. CNI-1493 mediated suppression of dendritic cell activation in vitro and in vivo. Immunobiology 2004, 209:89-97.